SCHEMBL25569446

SCHEMBL25569446

CCNCCNCCCNC(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.62
MEN1 O00255 1/20 0.62
GLA P06280 1/20 0.62
KMT2A Q03164 1/20 0.62
CYP1A2 P05177 1/20 0.59
SAT1 P21673 3/20 0.46
TSHR P16473 2/20 0.46
KDM1A O60341 5/20 0.44
ALDH1A1 P00352 1/20 0.36
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
CA14 Q9ULX7 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10045259 0.98 CYP2C19 (0.65) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL12319690 0.95 CYP2C19 (0.67) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL9010938 0.95 CYP2C19 (0.60) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL26107079 0.90 CYP2C19 (0.43) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL19749144 0.88 CYP2C19 (0.55) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL13893418 0.88 CYP2C19 (0.55) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL19308992 0.88 CYP2C19 (0.55) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL20003356 0.87 CYP2C19 (0.48) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL20003355 0.87 CYP2C19 (0.48) CYP2C19MEN1GLAKMT2ACYP1A2
SCHEMBL20733072 0.87 CYP2C19 (0.48) CYP2C19MEN1GLAKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY POLN, TLR9, TSG101 CYP2C19 4867/4885MEN1 2899/4885GLA 3196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.